Description
PF-06447475 inhibits leucine-rich repeat kinase 2 (LRRK2), exhibiting neuroprotective activity. In animal models of Parkinson’s disease, this compound suppresses neuroinflammation and neurodegeneration.
Product Unit Size | Cost | Quantity | Stock |
---|
PF-06447475 inhibits leucine-rich repeat kinase 2 (LRRK2), exhibiting neuroprotective activity. In animal models of Parkinson’s disease, this compound suppresses neuroinflammation and neurodegeneration.
Cas No. | 1527473-33-1 |
---|---|
Purity | ≥98% |
Formula | C17H15N5O |
Formula Wt. | 305.13 |
Chemical Name | 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile |
IUPAC Name | 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile |
Solubility | DMSO 61 mg/mL Water Insoluble Ethanol Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Daher JP, Abdelmotilib HA, Hu X, et al. LRRK2 Pharmacological Inhibition Abates α-Synuclein Induced Neurodegeneration. J Biol Chem. 2015 Jun 15. [Epub ahead of print]. PMID: 26078453.
Henderson JL, Kormos BL, Hayward MM, et al. Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J Med Chem. 2015 Jan 8;58(1):419-32. PMID: 25353650.
α7 nAChR partial agonist, 5-HT3 antagonist.
Jumonji histone demethylase inhibitor.
Abl inhibitor.
β-lactam cephalosporin; penicillin binding pro...
FIASMA; α1- and β1/2-adrenergic antagonist.
Naturally sourced ITC, sulfonyl analog of sulfo...
β1/2-adrenergic agonist.
α-Linked disaccharide composed of α-glucose u...
PAK4 inhibitor.
Alters membrane permeability, prevents transpor...
Laminin-derived peptapeptide.
STING antagonist
Endogenous sphingosine-based lipid, component o...
Abl inhibitor.
InsR and IGF-1R inhibitor.
Tetracycline; protein translation inhibitor, MM...
Synthetic progestogen; contraceptive.
Dihydropyridine; L-type Ca2+ channel blocker.
Endogenous opioid peptide; δOR and μOR agonis...
mTOR activator.